Skip to main navigation
  • Mission
  • Programs

        • Programs

          Learn more about our breakthrough programs.

        • Our Programs
        • Scientific Publications
  • People

        • About atai Life Sciences

          Learn about our team, culture and careers.

        • Our Team
        • Company Values
        • Careers
  • Impact
  • Investors

        • Investors

        • Overview
        • News, Events & Presentations
        • Stock Info
        • Analyst Coverage
        • Corporate Governance
        • SEC Filings
        • Shareholder Services

SEC Filing Details

Atai - Financials Submenu

  • SEC Filings
  • Annual Reports

Document Details

Form
10-Q/A
Filing Date
November 14, 2024
Document Date
September 30, 2024
Form Description
Amendment to a previously filed 10-Q
Filing Group
Quarterly Filings
Company
ATAI Life Sciences N.V.
Issuer
ATAI LIFE SCIENCES N.V.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT

Atai - Investor Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
logo

Atai - Footer Top

  • Mission
  • Model
  • Programs

atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Headquartered in Berlin, with offices in New York and London, our vision is to heal mental health disorders so that everyone everywhere can live a more fulfilled life.

atai Life Sciences N.V.
Wallstraße 16
10179 Berlin, Germany
Statutory Seat Amsterdam

linkedin twitter mail info@atai.life
  • People
  • Careers
  • News & Insights
  • Contact
Privacy & Cookies Policy

Atai - Footer Bottom

  • Impressum
  • Datenschutzerklärung
© 2024 ATAI Life Sciences N.V., All Rights Reserved